|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.55 CNY | +0.17% |
|
-4.08% | +21.43% |
| 05-19 | Gan & Lee Pharmaceuticals Completes First Patient Dosing in GZR102 Trial | MT |
| 04-25 | Gan & Lee Pharmaceuticals' 2024 Profit Jumps 81%, Operating Income Rises 17%; Shares Jump 10% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
Past dividends on Gan & Lee Pharmaceuticals.
| 10/06/2025 | Final Payment 1 CNY |
| 01/12/2024 | Interim Payment 0.5 CNY |
| 17/06/2024 | Annual 0.2 CNY |
| 19/06/2022 | Annual 0.3 CNY |
| 20/05/2021 | Annual 0.4 CNY |
| 19/08/2020 | Annual 0.5 CNY |
- Stock Market
- Equities
- 603087 Stock
- Charts Gan & Lee Pharmaceuticals.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition